Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Press Statements

      GSK and Vir Biotechnology announce US government agreement to purchase additional supply of sotrovimab, authorised for the early treatment of COVID-19

      Press Statements
      GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the US Government will purchase an additional 600,000 doses of sotrovimab, an investigational monoclonal antibody for...

      Catalent Increases Specialized Packaging Capabilities at its Philadelphia Facility to Support Growing Biologic and Cell and Gene Therapy Market

      Packaging & Logistic
      Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across...

      Envirotainer Welcomes Delta Cargo as the latest airline to approve the new Releye RLP container

      Manufacturing
      Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that Delta Cargo has approved the Envirotainer...

      LJI and Charles River Laboratories to collaborate on COVID-19 research

      Drug Development
      Scientists at La Jolla Institute for Immunology (LJI) and Charles River Laboratories International, Inc., are launching a new project to uncover exactly how different...

      CPhI predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity

      Press Statements
      CPhI Worldwide releases its beginning of year pharma market predictions for 2022 combining research from over 350 pharma executives and expert views from 10...

      Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of COVID-19 Vaccine in 2022

      Press Statements
      Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a revised supply agreement with the government of South Korea for...

      Ascletis expands production of ritonavir oral tablets & oral direct-acting antiviral R&D pipeline to treat SARS-CoV-2 infection

      Press Statements
      Ascletis Pharma Inc. announces the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.